Amyotrophic Lateral Sclerosis (ALS) otherwise known as Lou Gehrig’s Disease or Motor Neuron Disease (MND) is a fatal, rapidly progressive neuromuscular disease that affects approximately 3,000 Canadians and more than 430 Manitobans.
Amylyx Pharmaceuticals, Inc announced that Health Canada has approved ALBRIOZA (AMX0035) under a Notice of Compliance with Conditions (NOC/c). This decision came after a nearly 300-day review of theĀ drug's safety, efficacy...
April 5 is National Caregiver Day when we recognize the nearly 8 million Canadians who care for family and friends who have chronic health conditions, disabilities or functional limitations. Combining care work and paid work is the norm for many employed Canadians, with caregivers making up 30-35% of the paid workforce. Please join us in […]
Thank you for your help in making the 2021 Lite Up a Life campaign in support of the Brummitt Feasby ALS House a SUCCESS!! Every year, fromĀ November 1st to December 31st, the ALS Society of Manitoba runs the Lite Up a Life campaign to raise funds for special projects related to the Brummit Feasby […]
We are excited to announce that we are once again looking forward to an in-person Walk to End ALS! Time to dust off those walking shoes and step out into the beautiful surroundings of Assiniboine Park for a morning of fresh air and raise money to contribute towards finding a ...
Throw on your favourite purple shirt or sweater and show your support for ALS in June. Don’t own anything purple? Check out our MERCHANDISE! There are currently over 400 people suffering from ALS/MND in Manitoba alone. Your help allows us to offer programs to assist those living with ALS/MND to maintain independence and support research […]
A unique and wonderful way to give to the ALS Society of Manitoba is by holding a Third-Party Event. These fundraising events are planned by outside parties who give the proceeds to The ALS Society of Manitoba. Thank you to organizers and supporters! For more information or ideas on hosting an event, Contact Us or […]
Sign up for our CONNECT E-Newsletter and keep up to date with the ALS community. Get the latest news and stories about research, events, programs, and services delivered right to your inbox.